Surrozen Inc Ordinary Shares SRZN 深 滬
等待開盤 07-23 09:30:00 美东时间
8.65
-0.050
-0.57%
華盛通- 最 高8.98
- 今 開8.43
- 成交量 5.17万股
- 最 低 8.325
- 昨 收 8.70
- 總市值 7406.65万
- 52周最高 18.17
- 市盈率 靜 --
- 換手率 0.60%
- 52周最低 5.90
- 委 比 81.82%
- 總股本 856.26万
- 歷史最高 210.00
- 量 比 3.95
- 振 幅 7.53%
- 歷史最低 4.50
- 每 手 1
- 風險率 2.05%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Surrozen Granted US Patent To Antibody-Based Molecules Targeting Key Receptors In Wnt Pathway
Newly granted patent is part of the expanding intellectual property portfolio directed to:-generating novel and selective Wnt surrogate molecules with potentially broad therapeutic utility and-incorporating novel
05-14 20:38
美股大行评级 | 潜在涨幅455.56%！Medicus Pharma获D. Boral Capital升目标价至27美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1128971739548127232.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• D. Boral Capital：维持Medicus Pharma(MDCX)"买入"评级，目标价从14美元升至27美元</p> <p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从
05-13 08:50
HC Wainwright & Co. Reiterates Buy on Surrozen, Maintains $32 Price Target
HC Wainwright & Co. analyst Matthew Caufield reiterates Surrozen (NASDAQ:SRZN) with a Buy and maintains $32 price target.
05-12 18:59
Surrozen Q1 EPS $(7.43) Misses $(1.78) Estimate
Surrozen (NASDAQ:SRZN) reported quarterly losses of $(7.43) per share which missed the analyst consensus estimate of $(1.78) by 317.42 percent. This is a 75.24 percent decrease over losses of $(4.24) per share from the
05-10 04:07
Surrozen Focuses on Ophthalmology Amid Financial Challenges
Surrozen, Inc. ( ($SRZN) ) has released its Q4 earnings. Here is a breakdown of...
04-02 11:59
美股大行评级 | 大行唱多CING再涨340%！CORT获上调目标价至1320美元
Oppenheimer：上调Ovid Therapeutics(OVID)评级至"跑赢大市"，目标价4美元
01-31 15:37
Guggenheim Upgrades Surrozen to Buy, Maintains Price Target to $45
Guggenheim analyst Yatin Suneja upgrades Surrozen (NASDAQ:SRZN) from Neutral to Buy and maintains the price target from $45 to $45.
01-04 00:01
Surrozen, Inc.: Q3 2024 Earnings Overview
Surrozen, Inc. ( ($SRZN) ) has released its Q3 earnings. Here is a breakdown of...
2024-11-26 11:53
Surrozen GAAP EPS of -$0.44
Surrozen press release (NASDAQ:SRZN): Q3 GAAP EPS of -$0.44. Collaboration and license revenue of $10M, as compared to zero for the same period in 2023. Cash and cash equivalents were $31M as of Septe...
2024-11-06 23:12
